Tofighi, MojdehBaillet, GeorgesWeinmann, PierreMoretti, Jean Luc2023-06-122023-06-122004-02-28Tamgaç, F. vd. (2004). “The interest of (18)FDG-PET in the management of testicular cancer”. Presse Medicale, 33(4), 270-276.0755-4982https://doi.org/10.1016/S0755-4982(04)98554-5https://www.sciencedirect.com/science/article/pii/S0755498204985545http://hdl.handle.net/11452/33006The key to prognosis initial staging and early recurrence diagnosis are key parameters in the treatment and outcome of testicular cancer. Initial staging. It is difficult using conventional modalities, which can miss node involvement and are non-specific since enlargement does not rime with involvement. (18)FDG PET improves the accuracy of initial staging. Residual mass and recurrences Existence of residual mass or enhancement of its volume in the presence of an otherwise beneficial chemotherapy is difficult to manage. Several studies have demonstrated the value of (18)FDG imaging in such cases. As for follow-up whole body (18)FDG can prevent multiple diagnostic imaging and can diagnose recurrences with greater diagnostic accuracy than with other imaging modalities.eninfo:eu-repo/semantics/closedAccessGeneral and internal medicinePositron-emission-tomographyGerm-cell tumorsLymph-node metastasesAdvanced seminomaResidual massStage-IFDG PETChemotherapyResectionTherapyArticle0001893496000162-s2.0-144231436027027633415029020Medicine, general and internalLymph Node Dissection; Seminoma; Testicular Germ Cell TumorCancer chemotherapyCancer scintiscanningCancer stagingDiagnostic accuracyDiagnostic errorDiagnostic imagingHumanImaging systemLymph node metastasisParameterPositron emission tomographyPrognosisReviewTestis cancerTreatment outcomeFluorodeoxyglucose F 18